You are viewing: Rest Of Latin America Endoscopic Submucosal Dissection/ESD Market analysis

The Rest Of Latin America Endoscopic Submucosal Dissection/ESD Market was valued at $8.71 Million in 2025 and projected to reach to $13.52 Million by 2030, representing a compound annual growth rate of 9.2%. Rest Of Latin America's Endoscopic Submucosal Dissection market is poised for sustained growth through 2030, driven by escalating gastrointestinal cancer rates and improving healthcare infrastructure across the region.

Rest Of Latin America Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Latin America Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • This 9.2% compound annual growth rate reflects increasing adoption of minimally invasive endoscopic procedures across the region, driven by rising gastrointestinal cancer prevalence and improving healthcare infrastructure.
  • Rest Of Latin America is witnessing growing demand for advanced diagnostic and therapeutic endoscopic technologies as healthcare providers seek to enhance patient outcomes and reduce procedural complications. The expansion of Rest Of Latin America's ESD market is supported by enhanced physician training programs, increased investment in endoscopy centers, and greater patient awareness of early cancer detection benefits.
  • Rest Of Latin America's healthcare systems are progressively integrating ESD capabilities into their treatment protocols, particularly for early-stage gastric and colorectal lesions.
  • Between 2025 and 2030, Rest Of Latin America is expected to see accelerated market penetration as reimbursement policies evolve and medical device manufacturers expand their regional presence..

Key Market Statistics

  • CAGR (2025-2030) 9.2% CAGR
  • Market Size, 2025 ~USD 8.71 Million
  • Forecast, 2030 ~USD 13.52 Million
  • Country Rest Of Latin America

Rest Of Latin America Endoscopic Submucosal Dissection/ESD Market Overview

Market Valuation Growth :

Rest Of Latin America's ESD market is valued at USD 8.71 million in 2025, with strong expansion projected to USD 13.52 million by 2030, representing a 9.2% CAGR that outpaces the global average of 8.4%.

Rising GI Cancer Prevalence :

Increasing incidence of gastrointestinal cancers across Rest Of Latin America is driving demand for advanced endoscopic procedures, positioning ESD as a critical minimally invasive treatment option in the region.

Healthcare Infrastructure Improvements :

Expanding healthcare facilities and modernization of endoscopy centers across Rest Of Latin America are enabling wider adoption of ESD technology and training, supporting market penetration in underserved areas.

Minimally Invasive Procedure Adoption :

Growing physician and patient preference for minimally invasive endoscopic procedures over traditional surgery is accelerating ESD adoption in Rest Of Latin America, reducing recovery times and healthcare costs.

Rest Of Latin America Endoscopic Submucosal Dissection/ESD Market Dynamics

  • The 9.2% CAGR reflects increasing clinical adoption of ESD as a preferred treatment modality, supported by rising awareness among healthcare providers and patients regarding the benefits of minimally invasive procedures. Key growth catalysts include expanding endoscopy center capabilities, enhanced physician training programs, and growing healthcare investment in Rest Of Latin America.
  • Market expansion will be further supported by improving reimbursement policies and increasing patient access to advanced diagnostic and therapeutic endoscopic technologies, positioning the region as an emerging market for ESD device manufacturers and service providers..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Rest Of Latin America's ESD market is projected to grow from USD 8.71 million in 2025 to USD 13.52 million by 2030, representing a 9.2% CAGR.
    • Rest Of Latin America is experiencing increased adoption of minimally invasive endoscopic procedures driven by rising gastrointestinal cancer incidence and improved healthcare infrastructure.
    • Rest Of Latin America's market expansion is supported by enhanced physician training, growing endoscopy center investments, and evolving reimbursement policies.
    • Rest Of Latin America's healthcare providers are progressively integrating ESD capabilities for early-stage gastric and colorectal lesion treatment between 2025 and 2030.

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    Rest Of Latin America Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : ESD device and equipment manufacturers need Rest Of Latin America-specific market data to identify growth opportunities, assess market potential, and develop region-tailored product strategies and distribution partnerships.
    • Healthcare Providers & Hospital Networks : Hospital administrators and endoscopy center operators in Rest Of Latin America require market insights to justify ESD technology investments, benchmark performance, and plan service expansion strategies.
    • Private Equity & Investment Firms : Investors evaluating healthcare opportunities in Rest Of Latin America need detailed market analysis to assess investment returns, identify acquisition targets, and understand growth trajectories in the ESD sector.
    • Healthcare Consultants & Advisors : Management consulting firms and healthcare advisors serving Rest Of Latin America clients require region-specific ESD market data to support strategic planning, market entry, and competitive positioning recommendations.
    • Government & Healthcare Policy Bodies : Healthcare regulators and policy makers in Rest Of Latin America need market intelligence to inform reimbursement policies, healthcare infrastructure planning, and technology adoption initiatives for endoscopic procedures.

    Key Companies in the Rest Of Latin America Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuation data specific to Rest Of Latin America, including 2025 baseline (USD 8.71M) and 2030 projections (USD 13.52M), enabling accurate business planning and investment decisions for the region.
    • Competitive Landscape Intelligence : Understand key players, market share distribution, and competitive dynamics specific to Rest Of Latin America's ESD market, identifying partnership and expansion opportunities in this high-growth region.
    • Growth Driver Analysis : Gain insights into region-specific factors driving the 9.2% CAGR, including GI cancer prevalence trends, healthcare infrastructure development, and adoption patterns unique to Rest Of Latin America.
    • Market Entry & Expansion Strategy : Develop targeted go-to-market strategies for Rest Of Latin America by understanding local healthcare regulations, reimbursement frameworks, physician preferences, and patient demographics specific to the region.
    • Investment & Risk Assessment : Evaluate market attractiveness and growth potential in Rest Of Latin America through comprehensive analysis of market drivers, barriers, regulatory environment, and economic factors affecting ESD adoption.

    Frequently asked questions

    What is the current market size of ESD in Rest Of Latin America?

    Rest Of Latin America's ESD market was valued at USD 8.71 million in 2025 and is expected to grow to USD 13.52 million by 2030.

    What is the projected growth rate for Rest Of Latin America's ESD market?

    Rest Of Latin America's ESD market is projected to grow at a compound annual growth rate (CAGR) of 9.2% from 2025 to 2030.

    What factors are driving ESD market growth in Rest Of Latin America?

    Rest Of Latin America's ESD market growth is driven by rising gastrointestinal cancer prevalence, improved healthcare infrastructure, enhanced physician training, and increasing patient awareness of early cancer detection.

    Which lesion types are most commonly treated with ESD in Rest Of Latin America?

    Rest Of Latin America's healthcare providers primarily use ESD for early-stage gastric and colorectal lesion treatment, with growing adoption for other gastrointestinal indications.

    How is Rest Of Latin America's reimbursement landscape affecting ESD adoption?

    Rest Of Latin America's evolving reimbursement policies are progressively supporting ESD procedure coverage, facilitating increased market penetration and healthcare provider adoption between 2025 and 2030.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status